Leopold (Beijing) Medical Devices Co., Ltd. was founded in 1999, which is jointly funded by China Shipbuilding Industry Corporation (CSIC) 725 Research Institute and WP Corporation***. The company is mainly engaged in the research and development, production and sales of coronary interventional medical devices, and is one of the few domestic high-end medical devices that can form a strong competition with foreign products. Since its establishment, the company has successively completed the research, development and industrialization of a number of interventional medical core products, such as stents and catheters, and was the first one in the industry to obtain the product registration certificate of "Coronary Artery Stent Delivery System" issued by the State Drug Administration (Class III), and the first one to successfully develop and pilot-produce the anti-infection "drug central venous catheter". We are the first company in the industry to obtain the product registration certificate of "Coronary Stent Delivery System" (Class III) issued by the State Drug Administration, and the first company to develop and pilot produce the anti-infection central venous catheter.